Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
July-2020 Volume 57 Issue 1

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2020 Volume 57 Issue 1

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article

CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18

  • Authors:
    • Pedro Rosendo‑Chalma
    • Verónica Antonio‑Vejar
    • Gabriele Davide Bigoni‑Ordóñez
    • Carlos César Patiño‑Morales
    • Amparo Cano‑García
    • Alejandro García‑Carrancá
  • View Affiliations / Copyright

    Affiliations: Programa de Doctorado en Ciencias Biomédicas, Instituto de Investigaciones Biomédicas (IIB), Universidad Nacional Autónoma de México (UNAM), Mexico City 10450, Mexico, Laboratorio de Virus y Cáncer, Unidad de Investigación Biomédica en Cáncer of Instituto de Investigaciones Biomédicas‑Universidad Nacional Autónoma de México (IIB‑UNAM) and División de Investigación Básica of Instituto Nacional de Cancerología‑Secretaría de Salud (INCan‑SSA), Mexico City 14080, Mexico, Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas ‘Alberto Sols’ (CSIC‑UAM), Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid 28029, Spain
  • Pages: 301-313
    |
    Published online on: April 6, 2020
       https://doi.org/10.3892/ijo.2020.5039
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

A common characteristic of cancer types associated with viruses is the dysregulated expression of the CDH1 gene, which encodes E‑cadherin, in general by activation of DNA methyltransferases (Dnmts). In cervical cancer, E7 protein from high risk human papillomaviruses (HPVs) has been demonstrated to interact with Dnmt1 and histone deacetylase type 1 (HDAC1). The present study proposed that E7 may regulate the expression of CDH1 through two pathways: i) Epigenetic, including DNA methylation; and ii) Epigenetic‑independent, including the induction of negative regulators of CDH1 expression, such as Snail family transcriptional repressor Snai1 and Snai2. To test this hypothesis, HPV16‑ and HPV18‑positive cell lines were used to determine the methylation pattern of the CDH1 promoter and its expression in association with its negative regulators. Different methylation frequencies were identified in the CDH1 promoter in HeLa (88.24%) compared with SiHa (17.65%) and Ca Ski (0%) cell lines. Significant differences in the expression of SNAI1 were observed between these cell lines, and an inverse association was identified between the expression levels of SNAI1 and CDH1. In addition, suppressing E7 not only increased the expression of CDH1, but notably decreased the expression of SNAI1 and modified the methylation pattern of the CDH1 promoter. These results suggested that the expression of CDH1 was dependent on the expression of SNAI1 and was inversely associated with the expression of E7. The present results indicated that E7 from HPV16/18 regulated the expression of CDH1 by the two following pathways in which Snai1 is involved: i) Hypermethylation of the CDH1 promoter region and increasing expression of SNAI1, as observed in HeLa; and ii) Hypomethylation of the CDH1 promoter region and expression of SNAI1, as observed in SiHa. Therefore, the suppression of CDH1 and expression of SNAI1 may be considered to be biomarkers of metastasis in uterine cervical cancer.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar

2 

Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar : PubMed/NCBI

3 

zur Hausen H: Papillomaviruses in the causation of human cancers-a brief historical account. Virology. 384:260–265. 2009. View Article : Google Scholar : PubMed/NCBI

4 

Bansal A, Singh MP and Rai B: Human papillomavirus-associated cancers: A growing global problem. Int J Appl Basic Med Res. 6:84–89. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Doorbar J: Latent papillomavirus infections and their regulation. Curr Opin Virol. 3:416–421. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, Stanley MA and Franceschi S: Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2:160862016. View Article : Google Scholar : PubMed/NCBI

8 

Durst M, Kleinheinz A, Hotz M and Gissmann L: The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol. 66:1515–1522. 1985. View Article : Google Scholar : PubMed/NCBI

9 

Lehn H, Villa LL, Marziona F, Hilgarth M, Hillemans HG and Sauer G: Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. J Gen Virol. 69:187–196. 1988. View Article : Google Scholar : PubMed/NCBI

10 

Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LS, Li BF and Bernard HU: The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology. 324:483–492. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Fernandez AF, Rosales C, Lopez-Nieva P, Graña O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambio A, Fraga MF, et al: The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res. 19:438–451. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Kalantari M, Lee D, Calleja-Macias IE, Lambert PF and Bernard HU: Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology. 374:292–303. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Boyer SN, Wazer DE and Band V: E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56:4620–4624. 1996.PubMed/NCBI

14 

Munger K, Phelps WC, Bubb V, Howley PM and Schlegel R: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 63:4417–4421. 1989. View Article : Google Scholar : PubMed/NCBI

15 

Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ and Kouzarides T: The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J. 18:2449–2458. 1999. View Article : Google Scholar : PubMed/NCBI

16 

Burgers WA, Blanchon L, Pradhan S, de Launoit Y, Kouzarides T and Fuks F: Viral oncoproteins target the DNA methyltransfer-ases. Oncogene. 26:1650–1655. 2007. View Article : Google Scholar

17 

Longworth MS and Laimins LA: The binding of histone deacety-lases and the integrity of zinc finger‑like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31. J Virol. 78:3533–3541. 2004. View Article : Google Scholar : PubMed/NCBI

18 

Zhang Y, LeRoy G, Seelig HP, Lane WS and Reinberg D: The dermatomyositis‑specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remod-eling activities. Cell. 95:279–289. 1998. View Article : Google Scholar : PubMed/NCBI

19 

Li H, Ou X, Xiong J and Wang T: HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter. Biochem Biophys Res Commun. 349:1315–1321. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Georgopoulos NT, Proffitt JL and Blair GE: Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papilloma-virus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene. 19:4930–4935. 2000. View Article : Google Scholar : PubMed/NCBI

21 

Milutin Gasperov N, Sabol I, Planinić P, Grubišić G, Fistonić I, Ćorušić A and Grce M: Methylated host cell gene promoters and human papillomavirus type 16 and 18 predicting cervical lesions and cancer. PLoS One. 10:e01294522015. View Article : Google Scholar : PubMed/NCBI

22 

Liu J, Lian Z, Han S, Waye MM, Wang H, Wu MC, Wu K, Ding J, Arbuthnot P, Kew M, et al: Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene. 25:1008–1017. 2006. View Article : Google Scholar

23 

McLaughlin-Drubin ME and Munger K: Viruses associated with human cancer. Biochim Biophys Acta. 1782:127–150. 2008. View Article : Google Scholar : PubMed/NCBI

24 

Tsai CN, Tsai CL, Tse KP, Chang HY and Chang YS: The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA. 99:10084–10089. 2002. View Article : Google Scholar : PubMed/NCBI

25 

Caberg JH, Hubert PM, Begon DY, Herfs MF, Roncarati PJ, Boniver JJ and Delvenne PO: Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis. 29:1441–1447. 2008. View Article : Google Scholar : PubMed/NCBI

26 

Laurson J, Khan S, Chung R, Cross K and Raj K: Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein. Carcinogenesis. 31:918–926. 2010. View Article : Google Scholar : PubMed/NCBI

27 

Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2:76–83. 2000. View Article : Google Scholar : PubMed/NCBI

28 

Pattillo RA, Hussa RO, Story MT, Ruckert AC, Shalaby MR and Mattingly RF: Tumor antigen and human chorionic gonadotropin in CaSki cells: A new epidermoid cervical cancer cell line. Science. 196:1456–1458. 1977. View Article : Google Scholar : PubMed/NCBI

29 

Friedl F, Kimura I, Osato T and Ito Y: Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I Its establishment and morphology. Proc Soc Exp Biol Med. 135:543–545. 1970. View Article : Google Scholar : PubMed/NCBI

30 

Diao MK, Liu CY, Liu HW, Li JT, Li F, Mehryar MM, Wang YJ, Zhan SB, Zhou YB, Zhong RG and Zeng Y: Integrated HPV genomes tend to integrate in gene desert areas in the CaSki, HeLa, and SiHa cervical cancer cell lines. Life Sci. 127:46–52. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R and Howley PM: Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol. 119:361–366. 1985.PubMed/NCBI

32 

Schneider-Gädicke A and Schwarz E: Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5:2285–2292. 1986. View Article : Google Scholar : PubMed/NCBI

33 

Pater MM and Pater A: Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology. 145:313–318. 1985. View Article : Google Scholar : PubMed/NCBI

34 

Pater MM and Pater A: Expression of human papillomavirus types 16 and 18 DNA sequences in cervical carcinoma cell lines. J Med Virol. 26:185–195. 1988. View Article : Google Scholar : PubMed/NCBI

35 

Spence RP, Murray A, Banks L, Kelland LR and Crawford L: Analysis of human papillomavirus sequences in cell lines recently derived from cervical cancers. Cancer Res. 48:324–328. 1988.PubMed/NCBI

36 

Meissner JD: Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol. 80:1725–1733. 1999. View Article : Google Scholar : PubMed/NCBI

37 

De la Cruz-Hernandez E, Garcia-Carranca A, Mohar-Betancourt A, Dueñas-González A, Contreras-Paredes A, Pérez-Cardenas E, Herrera-Goepfert R and Lizano-Soberón M: Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences. J Gen Virol. 86:2459–2468. 2005. View Article : Google Scholar : PubMed/NCBI

38 

Vazquez-Vega S, Sanchez-Suarez LP, Andrade-Cruz R, Castellanos-Juarez E, Contreras-Paredes A, Lizano-Soberon M, Garcia-Carranca A and Benitez Bribiesca L: Regulation of p14ARF expression by HPV-18 E6 variants. J Med Virol. 85:1215–1221. 2013. View Article : Google Scholar : PubMed/NCBI

39 

Vazquez-Vega S, Sanchez-Suarez LP, Contreras-Paredes A, Castellanos-Juárez E, Peñarroja-Flores R, Lizano-Soberón M, Andrade-Cruz R, García-Carrancá A and Benítez-Bribiesca L: Nuclear co-expression of p14ARF and p16INK4A in uterine cervical cancer-derived cell lines containing HPV. Cancer Biomark. 8:341–350. 2011. View Article : Google Scholar

40 

Gutier rez J, Ga rcia-Villa E, Ocadiz-Delgado R, Cortés-Malagón EM, Vázquez J, Roman-Rosales A, Alvarez-Rios E, Celik H, Romano MC, Üren A, et al: Human papillomavirus type 16 E7 oncoprotein upregulates the retinoic acid receptor-beta expression in cervical cancer cell lines and K14E7 transgenic mice. Mol Cell Biochem. 408:261–272. 2015. View Article : Google Scholar

41 

Momparler RL: Epigenetic therapy of cancer with 5-aza-2'-deox-ycytidine (decitabine). Semin Oncol. 32:443–451. 2005. View Article : Google Scholar : PubMed/NCBI

42 

Vigushin DM, Ali S, Pace PE, Mirsaidi N, Ito K, Adcock I and Coombes RC: Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res. 7:971–976. 2001.PubMed/NCBI

43 

Jiang M and Milner J: Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene. 21:6041–6048. 2002. View Article : Google Scholar : PubMed/NCBI

44 

Lea JS, Sunaga N, Sato M, Kalahasti G, Miller DS, Minna JD and Muller CY: Silencing of HPV 18 oncoproteins with RNA interference causes growth inhibition of cervical cancer cells. Reprod Sci. 14:20–28. 2007. View Article : Google Scholar : PubMed/NCBI

45 

Sledz CA, Holko M, de Veer MJ, Silverman RH and Williams BR: Activation of the interferon system by short-interfering RNAs. Nat Cell Biol. 5:834–839. 2003. View Article : Google Scholar : PubMed/NCBI

46 

Makpol S, Zainuddin A and Chua KH: GAPDH expression as a measurement of transfection efficiency for p16 INK4a gene silencing (siRNA) in senescent human diploid fibroblasts. Am J Mol Biol. 2:390–397. 2012. View Article : Google Scholar

47 

Han H: RNA interference to knock down gene expression. Methods Mol Biol. 1706:293–302. 2018. View Article : Google Scholar : PubMed/NCBI

48 

Borawski J, Lindeman A, Buxton F, Labow M and Gaither LA: Optimization procedure for small interfering RNA transfection in a 384-well format. J Biomol Screen. 12:546–559. 2007. View Article : Google Scholar : PubMed/NCBI

49 

Peter Hahn JD, Wolfgang Bielke and Kang Jie: Patent: EP2240582 B1-Positive controls for expression modulating experiments. European Patent Office. October 23–2013.

50 

Cheng A, Magdaleno S and Vlassov AV: Optimization of trans-fection conditions and analysis of siRNA potency using real-time PCR. Methods Mol Biol. 764:199–213. 2011. View Article : Google Scholar

51 

Badal V, Chuang LS, Tan EH, Badal S, Villa LL, Wheeler CM, Li BF and Bernard HU: CpG methylation of human papilloma-virus type 16 DNA in cervical cancer cell lines and in clinical specimens: Genomic hypomethylation correlates with carcinogenic progression. J Virol. 77:6227–6234. 2003. View Article : Google Scholar : PubMed/NCBI

52 

Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Lie K, Barrera-Saldana HA, Wiley DJ and Bernard HU: Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol. 78:12762–12772. 2004. View Article : Google Scholar : PubMed/NCBI

53 

Hoffmann I, Hilger M and Mueller O: Homo sapiens promoter of E-cadherin from HEK293 cells. Max-Planck-Institut fuer Molekulare Physiologie; Dortmund: 2006

54 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

55 

Peinado H, Portillo F and Cano A: Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol. 48:365–375. 2004. View Article : Google Scholar : PubMed/NCBI

56 

Moreno-Bueno G, Cubillo E, Sarrio D, Peinado H, Rodríguez-Pinilla SM, Villa S, Bolós V, Jordá M, Fabra A, Portillo F, et al: Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 66:9543–9556. 2006. View Article : Google Scholar : PubMed/NCBI

57 

Peinado H, Olmeda D and Cano A: Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI

58 

Cameron EE, Bachman KE, Myöhänen S, Herman JG and Baylin SB: Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet. 21:103–107. 1999. View Article : Google Scholar : PubMed/NCBI

59 

Ou JN, Torrisani J, Unterberger A, Provençal N, Shikimi K, Karimi M, Ekström TJ and Szyf M: Histone deacetylase inhibitor Trichostatin A induces global and gene‑specific DNA demeth-ylation in human cancer cell lines. Biochem Pharmacol. 73:1297–1307. 2007. View Article : Google Scholar : PubMed/NCBI

60 

Meng F, Sun G, Zhong M, Yu Y and Brewer MA: Anticancer efficacy of cisplatin and trichostatin A or 5‑aza‑2'‑deoxycytidine on ovarian cancer. Br J Cancer. 108:579–586. 2013. View Article : Google Scholar : PubMed/NCBI

61 

Liu YN, Lee WW, Wang CY, Chao TH, Chen Y and Chen JH: Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene. 24:8277–8290. 2005. View Article : Google Scholar : PubMed/NCBI

62 

Chen Y, Wang K, Qian CN and Leach R: DNA methylation is associated with transcription of Snail and Slug genes. Biochem Biophys Res Commun. 430:1083–1090. 2013. View Article : Google Scholar :

63 

Savagner P, Kusewitt DF, Carver EA, Magnino F, Choi C, Gridley T and Hudson LG: Developmental transcription factor slug is required for effective re-epithelialization by adult kerati-nocytes. J Cell Physiol. 202:858–866. 2005. View Article : Google Scholar

64 

Arzumanyan A, Friedman T, Kotei E, Ng IO, Lian Z and Feitelson MA: Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. Oncogene. 31:563–572. 2012. View Article : Google Scholar

65 

Horikawa T, Yoshizaki T, Kondo S, Furukawa M, Kaizaki Y and Pagano JS: Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Br J Cancer. 104:1160–1167. 2011. View Article : Google Scholar : PubMed/NCBI

66 

Liu H, Xu L, He H, Zhu Y, Liu J, Wang S, Chen L, Wu Q, Xu J and Gu J: Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein. Cancer Sci. 103:2072–2081. 2012. View Article : Google Scholar : PubMed/NCBI

67 

Nie D, Shan X, Nie L, Duan Y, Chen Z, Yang Y, Li Z, Tian L, Gao Q, Shan Y and Tang N: Hepatitis C virus core protein interacts with Snail and histone deacetylases to promote the metastasis of hepatocellular carcinoma. Oncogene. 35:3626–3635. 2016. View Article : Google Scholar

68 

Liu K, Tang Z, Huang A, Chen P, Liu P, Yang J, Lu W, Liao J, Sun Y, Wen S, et al: Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression. Int J Oncol. 50:252–262. 2017. View Article : Google Scholar

69 

Liu Y, Xu Y, Ma H, Wang B, Xu L, Zhang H, Song X, Gao L, Liang X and Ma C: Hepatitis B virus X protein amplifies TGF‑β promotion on HCC motility through down-regulating PPM1a. Oncotarget. 7:33125–33135. 2016. View Article : Google Scholar : PubMed/NCBI

70 

Park GB, Kim D, Kim YS, Kim S, Lee HK, Yang JW and Hur DY: The Epstein-Barr virus causes epithelial-mesenchymal transition in human corneal epithelial cells via Syk/src and Akt/Erk signaling pathways. Invest Ophthalmol Vis Sci. 55:1770–1779. 2014. View Article : Google Scholar : PubMed/NCBI

71 

Sides MD, Klingsberg RC, Shan B, Gordon KA, Nguyen HT, Lin Z, Takahashi T, Flemington EK and Lasky JA: The Epstein-Barr virus latent membrane protein 1 and transforming growth factor-β1 synergistically induce epithelial–mesenchymal transition in lung epithelial cells. Am J Respir Cell Mol Biol. 44:852–862. 2011. View Article : Google Scholar

72 

Taniguchi H, Kato N, Otsuka M, Goto T, Yoshida H, Shiratori Y and Omata M: Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. J Med Virol. 72:52–59. 2004. View Article : Google Scholar

73 

Peinado H, Quintanilla M and Cano A: Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: Mechanisms for epithelial mesenchymal transitions. J Biol Chem. 278:21113–21123. 2003. View Article : Google Scholar : PubMed/NCBI

74 

Surviladze Z, Sterk RT, DeHaro SA and Ozbun MA: Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy. J Virol. 87:2508–2517. 2013. View Article : Google Scholar :

75 

Menges CW, Baglia LA, Lapoint R and McCance DJ: Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res. 66:5555–5559. 2006. View Article : Google Scholar : PubMed/NCBI

76 

Yi JY, Hur KC, Lee E, Jin YJ, Arteaga CL and Son YS: TGFbeta1-mediated epithelial to mesenchymal transition is accompanied by invasion in the SiHa cell line. Eur J Cell Biol. 81:457–468. 2002. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Rosendo‑Chalma P, Antonio‑Vejar V, Bigoni‑Ordóñez GD, Patiño‑Morales CC, Cano‑García A and García‑Carrancá A: CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18. Int J Oncol 57: 301-313, 2020.
APA
Rosendo‑Chalma, P., Antonio‑Vejar, V., Bigoni‑Ordóñez, G.D., Patiño‑Morales, C.C., Cano‑García, A., & García‑Carrancá, A. (2020). CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18. International Journal of Oncology, 57, 301-313. https://doi.org/10.3892/ijo.2020.5039
MLA
Rosendo‑Chalma, P., Antonio‑Vejar, V., Bigoni‑Ordóñez, G. D., Patiño‑Morales, C. C., Cano‑García, A., García‑Carrancá, A."CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18". International Journal of Oncology 57.1 (2020): 301-313.
Chicago
Rosendo‑Chalma, P., Antonio‑Vejar, V., Bigoni‑Ordóñez, G. D., Patiño‑Morales, C. C., Cano‑García, A., García‑Carrancá, A."CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18". International Journal of Oncology 57, no. 1 (2020): 301-313. https://doi.org/10.3892/ijo.2020.5039
Copy and paste a formatted citation
x
Spandidos Publications style
Rosendo‑Chalma P, Antonio‑Vejar V, Bigoni‑Ordóñez GD, Patiño‑Morales CC, Cano‑García A and García‑Carrancá A: CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18. Int J Oncol 57: 301-313, 2020.
APA
Rosendo‑Chalma, P., Antonio‑Vejar, V., Bigoni‑Ordóñez, G.D., Patiño‑Morales, C.C., Cano‑García, A., & García‑Carrancá, A. (2020). CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18. International Journal of Oncology, 57, 301-313. https://doi.org/10.3892/ijo.2020.5039
MLA
Rosendo‑Chalma, P., Antonio‑Vejar, V., Bigoni‑Ordóñez, G. D., Patiño‑Morales, C. C., Cano‑García, A., García‑Carrancá, A."CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18". International Journal of Oncology 57.1 (2020): 301-313.
Chicago
Rosendo‑Chalma, P., Antonio‑Vejar, V., Bigoni‑Ordóñez, G. D., Patiño‑Morales, C. C., Cano‑García, A., García‑Carrancá, A."CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18". International Journal of Oncology 57, no. 1 (2020): 301-313. https://doi.org/10.3892/ijo.2020.5039
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team